A. Polyzos

发表

A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer

D. Mavroudis, V. Georgoulias, N. Malamos, 2011, Cancer Chemotherapy and Pharmacology.

Clinical Features of Hypersensitivity Reactions to Oxaliplatin: A 10-Year Experience

G. Kouraklis, J. Griniatsos, E. Felekouras, 2008, Oncology.

Irinotecan as Salvage Chemotherapy for Advanced Small Bowel Adenocarcinoma: A Series of Three Patients

G. Kouraklis, J. Bramis, J. Delladetsima, 2003, Journal of chemotherapy.

Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer.

K. Syrigos, G. Kouraklis, H. Gogas, 2003, Anticancer research.

Detection of Circulating Tumor Cells in Prostate Cancer Patients: Methodological Pitfalls and Clinical Relevance

M. Koutsilieris, C. Deliveliotis, A. Sourla, 2009, Molecular medicine.

Full Dose Paclitaxel Plus Vinorelbine as Salvage Chemotherapy in Anthracycline-Resistant Advanced Breast Cancer: A Phase II Study

G. Kouraklis, G. Kouraklis, H. Gogas, 2003, Journal of chemotherapy.

Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia.

E. Estey, H. Kantarjian, M. Keating, 1992, The American journal of medicine.

Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.

H. Gogas, C. Markopoulos, N. Tsavaris, 2009, Anticancer research.

Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.

V. Georgoulias, C. Kosmidis, C. Kosmas, 2005, Anticancer research.

Double Biochemical Modulation of 5-Fluorouracil by Methotrexate and Folinic Acid for the Treatment of Advanced Colorectal Cancer

C. Kosmas, G. Karatzas, A. Polyzos, 1999 .

FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

Vassilis Georgoulias, A. Adamou, D. Mavroudis, 2009, Breast Cancer Research and Treatment.

Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study.

J. Griniatsos, K. Syrigos, N. Nikiteas, 2012, Anticancer research.

Phase II study of gemcitabine plus 5-fluorouracil biologically modulated by folinic acid plus long-acting formulation of octreotide (LAR) in patients with advanced pancreatic cancer.

J. Griniatsos, E. Felekouras, G. Nikou, 2005, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma

K. Syrigos, V. Georgoulias, L. Vamvakas, 2005, Cancer Chemotherapy and Pharmacology.

Cisplatin-Ifosfamide-gemcitabine as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and Paclitaxel.

H. Gogas, E. Felekouras, C. Tsigris, 2009, Anticancer research.

Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.

G. Kouraklis, H. Gogas, J. Griniatsos, 2007, Anticancer research.

Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin.

G. Kouraklis, H. Gogas, J. Griniatsos, 2006, Anticancer research.

Primary extraskeletal osteosarcoma of the penis with a malignant fibrous histiocytoma‐like component

G. Rassidakis, A. Yannopoulos, A. Polyzos, 1998, Histopathology.

FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

A. Adamou, D. Mavroudis, V. Georgoulias, 2009, Breast Cancer Research and Treatment.